Literature DB >> 6785411

Time course and disposition of methazolamide in human plasma and red blood cells.

W F Bayne, F T Tao, G Rogers, L C Chu, F Theeuwes.   

Abstract

Methazolamide was determined in plasma, whole blood, and urine by a GLC-mass spectrometric method. Temporal patterns of methazolamide concentrations in plasma and red blood cells were obtained following single- and multiple-dose oral administration of the drug. The nonlinearity in the binding of the drug to the red blood cell carbonic anhydrase was evident from a comparison of plasma and red blood cells concentrations. The drug was cleared slowly from the red blood cells. The binding constants to the two isoenzymes of carbonic anhydrase were determined from the plasma and red blood cell concentrations and were in agreement with those determined by previous measurements. The half-life of elimination was 7.5 hr. The urinary recovery of unchanged drug was approximately 25% of the administered dose.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6785411     DOI: 10.1002/jps.2600700115

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  3 in total

1.  Simulation of the pharmacokinetic profile of methazolamide in blood: effect of erythrocyte carbonic anhydrase binding on drug disposition.

Authors:  Malaz A AbuTarif; David R Taft
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

2.  A semi-physiological population pharmacokinetic model describing the non-linear disposition of indisulam.

Authors:  Anthe S Zandvliet; Jan H M Schellens; William Copalu; Jos H Beijnen; Alwin D R Huitema
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-09-01       Impact factor: 2.745

3.  In vitro characterization of the erythrocyte distribution of methazolamide: a model of erythrocyte transport and binding kinetics.

Authors:  G R Iyer; R A Bellantone; D R Taft
Journal:  J Pharmacokinet Biopharm       Date:  1999-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.